ChiCTR2000031787: A Clinical Study to Evaluate Safety and Efficacy of ARQ 087 in Chinese Inoperable, Recurrent or Metastatic Intrahepatic Cholangiocarcinoma Subjects With Advanced Solid Tumors and FGFR2 Gene Fusion Positive Who Failed at Least First-Line Systemic Therapy |
|
|
| Recruiting | N/A | 110 | | ARQ087 ;ARQ087 | Peking University Cancer Hospital & Institute; Sinovant Sciences Co., Ltd., self-financing | Solid Tumor and Intrahepatic Cholangiocarcinoma | | | | |